Skip to main content
. 2019 Nov 10;21(3):223–230. doi: 10.1080/15384047.2019.1683324

Figure 2.

Figure 2.

Lapatinib AUC in the brain of wild-type mice (n = 3 at each timepoint) when treated with lapatinib alone or in combination with botryllamide G (a) and exposure curve over 24 h. Lapatinib AUC in the plasma of wild-type mice (n = 3 at each timepoint) when treated with lapatinib alone or in combination with botryllamide G (b) and exposure curve over 24 h. Error bars represent mean standard deviation.